Clinical Trial Update: 23andMe IPF Research Study

View source ↗

Summary

This is a clinical trial update for the 23andMe IPF research study. The study on idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: 23andMe, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED